Executive Officers

Justin Dearborn, 52
Co-Chief Executive Officer and Director

Justin Dearborn has over 25 years of experience leading healthcare, technology and publishing businesses and is currently serving as the Chief Executive Officer of PatientBond, Inc., a digital patient engagement company powered by healthcare consumer psychographics. Before his role as Chief Executive Officer of PatientBond, Mr. Dearborn served as Chief Executive Officer of Tribune Publishing Company (Nasdaq: TPCO), a media company, from 2016 to 2019 and as Chief Executive Officer and Chairman from 2018 to 2019. Mr. Dearborn was chief executive officer of eMed, an at-home diagnostic testing company, in 2020. Mr. Dearborn was Chief Operating Officer for ICM Partners, a leading talent agency, in 2019. Prior to Tribune, he served as Chief Executive Officer and a director of Merge Healthcare Incorporated (Nasdaq: MRGE), a clinical software solution provider from 2008 until 2016. During his tenure, Mr. Dearborn led the company through a period of transformation and sustainable growth. While serving as Chief Executive Officer of Merge, he executed a multi-faceted growth strategy comprised of significant investments in sales and marketing capabilities across Merge’s core solution offerings while pursuing acquisitions to broaden market reach into adjacent sectors and to increase capabilities and share of current solution offerings. Mr. Dearborn joined Merge as Chief Executive Officer when Merge’s enterprise value was approximately $10 million. Merge was acquired by IBM for $1 billion in 2015 and was integrated into IBM’s Watson Health division to deliver intuitive, cognitive computing solutions to healthcare providers. Over his career, Mr. Dearborn has led the acquisition of numerous companies, including the sales of Merge and the LA Times. Before joining Merge, Mr. Dearborn served as managing director at Merrick Ventures, LLC, a private investment firm. In addition to serving on the board of directors of PatientBond, Mr. Dearborn is serving out his final term as a director and Chairman of the Audit Committee of Next Level Health, an Illinois based Medicaid insurance provider that was acquired by Centene Corporation in 2020. Mr. Dearborn received his B.S. in Accounting from Illinois State University and his J.D. from Depaul College of Law.

Jonathan Phillips, 48
Co-Chief Executive Officer and Director

Jonathan Phillips has over 25 years of experience in healthcare information technology, healthcare services, investment banking and private investing. Mr. Phillips has served as Managing Director and Head of Private Equity for FTCP, headquartered in Wheaton, Illinois, since November 2016. Mr. Phillips is also the founder and Managing Partner of First Health Capital Partners, LLC, a healthcare technology and services investment firm founded in January 2016. Mr. Phillips has led investments in a broad range of healthcare technology and services companies, including Vivify Health (acquired by United Health Group in 2019), Lightbeam Health, AVIA, RxAnte, and Wellvana Health. Before his role at First Trust Capital Partners, in 2005, Mr. Phillips founded Healthcare Growth Partners, LLC, a provider of strategic and financial advisory services to healthcare technology companies, and he served as its Managing Director until November 2016. Prior to founding Healthcare Growth Partners, Mr. Phillips was a member of the Healthcare Investment Banking Group at William Blair, an investment banking firm. Prior to William Blair, he served in various roles in the healthcare practice of Deloitte Consulting. Mr. Phillips currently serves as a director and as the Audit Committee chair for Streamline Health (Nasdaq: STRM), a publicly traded healthcare information technology company. In addition, Mr. Phillips serves on the boards of a number of private companies including AVIA, Conversio Health, Cordata Healthcare Innovations, Lightbeam Health, PatientBond, RxAnte, Wellbox and Wellvana. Mr. Phillips has completed over 115 transactions involving healthcare companies and has completed over 40 strategic advisory engagements for healthcare technology and services companies. Mr. Phillips earned his MBA in Finance, Marketing and Health Services Management from the J. L. Kellogg School of Management, Northwestern University, and his BA in Economics and Management from DePauw University.

Board of Directors

Charles Martin, 78
Chairman

Charles Martin is the founder and Chairman of Martin Ventures, a Nashville-based investment firm he founded in 2009. Mr. Martin has more than 50 years of experience operating large, complex healthcare systems. At Martin Ventures, he leads an investment firm dedicated to building and investing in healthcare technology, healthcare services and healthcare technology-enabled services companies that optimize existing healthcare provider businesses, develop new and innovative models of care, and empower the healthcare consumer. Martin Ventures has a current portfolio of 20 healthcare companies and has successfully exited an additional 13 healthcare investments. Prior to launching Martin Ventures, Mr. Martin founded Vanguard Health Systems and served as Vanguard’s Founder, Chairman, and Chief Executive Officer for 16 years. Vanguard went public in 2011, and in 2013 was acquired by Tenet Healthcare for $4.3 billion. Before launching Vanguard, Mr. Martin, in conjunction with private equity partners, acquired the hospital chain Republic Health, ultimately founding a new healthcare system called OrNda Healthcare Corp. OrNda became the nation’s third-largest investor-owned hospital chain with 53 hospitals before being sold to Tenet Healthcare Corp. in 1997 for $1.8 billion. Earlier in Mr. Martin’s career, he served in numerous executive roles with Hospital Corporation of America, Inc., General Care Corp. and HealthTrust, Inc.Mr. Martin has also served on numerous boards of directors, including the University of Pennsylvania Law School and RAND Health, an independent health research group. Mr. Martin received his B.A. from Southern Adventist University.

Matthew Etheridge, 49
Director Nominee

Matthew Etheridge is a private investor with over 20 years of investment management experience, with a primary focus on healthcare services and information technology. He has invested in and served on the board of directors of several public and private companies in these areas, including NaviHealth (acquired by Cardinal Health in 2018) Universal American Corp. (NYSE: UAM; acquired by Wellcare in 2017), Lightbeam Health Solutions, Healthmine and Conversio Health. Previously, Mr. Etheridge was a Managing Partner of Perry Capital LLC, a private investment management firm, where he was Co-Portfolio Manager of the firm’s healthcare group, which managed public and private investments in healthcare and other industries. Prior to joining Perry Capital in 2001, Mr. Etheridge was an investment analyst for Stanford Management Company, the investment manager of Stanford University’s endowment. Prior to joining Stanford Management in 1997, Mr. Etheridge was a consultant with McKinsey & Company. Mr. Etheridge received his J.D. from Stanford Law School and his A.B. in Economics from Stanford University.

Jeremy Friese, 46
Director Nominee

Jeremy Friese, M.D., is a physician executive with a demonstrated passion for improving healthcare, first as an academic physician leader at Mayo Clinic then as an entrepreneur with various healthcare companies. Dr. Friese currently serves as President, Payer Market at Olive, a developer of process automation software designed to build meaningful artificial intelligence for healthcare payers and providers. Prior to Olive, Dr. Friese ran Invenshure, a healthcare venture incubator, and co-founded and led Verata Health, a venture-backed AI technology company that pioneered Frictionless Prior Authorization® for payers and providers, and which was acquired by Olive in 2020. Prior to his transition to entrepreneurship, Dr. Friese was a physician and executive at the Mayo Clinic and Harvard University. During his Mayo career, he held executive leadership positions for the imaging service line, the Mayo Clinic Strategic Investment Fund, and Global Business Development. Additionally, Dr. Friese served on several boards of directors, including the International Monetary Fund and the American Cancer Society. Dr. Friese earned his MD at the Mayo Clinic College of Medicine and Science and his MBA at Harvard Business School.

Kelly Richmond Pope, 47
Director Nominee

Kelly Richmond Pope, Ph.D., is a professor in the School of Accountancy and Management Information Systems at DePaul University. Prior to joining DePaul, she worked in the forensic accounting practice at KPMG, LLP on anti-money laundering engagements, insurance fraud investigations and fraud risk management projects. She was named as one of the 25 most powerful women in accounting by the AICPA and CPA Practice Advisor. She currently serves as director and chair of the Audit Committee for the Greater Chicago Food Depository. She is former director and finance chair for Mercy Hospital & Medical Center, former director of the Illinois CPA Society and former member of the governing council for the AICPA. She received her doctorate in accounting from Virginia Tech and she is a licensed certified public accountant.

John Glaser, 66
Director Nominee

John Glaser, Ph.D., is a former senior vice president of Population Health at Cerner Corporation from 2015 to 2019. Prior to such time, he was Chief Executive Officer of Siemens Heath Services from 2010 to 2015. Prior to Siemens, Dr. Glaser was Chief Information Officer at Partners HealthCare. He was the founding chair of CHIME and the past-president of the Healthcare Information and Management Systems Society. He is the former Chair of the Global Agenda Council on Digital Health, World Economic Forum. He is former Senior Advisor to the Office of the National Coordinator for Health Information Technology. Dr. Glaser serves on the boards of directors of the Scottsdale Institute, Intouch Health, PatientPing, National Committee for Quality Assurance, the American Telemedicine Association, Wellsheet and Relatient. Dr. Glaser has received numerous industry awards, including the John P. Glaser Innovation Award (established by the School of Biomedical Informatics, UTHealth), William B. Stead Thought Leadership Award (American Medical Informatics Association) and the Lifetime Achievement Award (CHIME). He has authored many articles and books on the strategic application of IT in health care. He is on the faculty of the Wharton School at the University of Pennsylvania, the UTHealth School of Biomedical Informatics and the Harvard School of Public Health.

Anthony Sanzo, 67
Director Nominee

Anthony Sanzo has been a healthcare and healthcare information technology executive for over 20 years and brings a deep understanding of the operational challenges faced by healthcare providers and the ways that technology solutions can be deployed to address them. Mr. Sanzo currently serves as Chairman of the Board of Net Health Systems, a specialized electronic health record software and services vendor providing technology solutions that address the continuum of care from hospital to home. Prior to his role as Chairman, Mr. Sanzo was Chief Executive Officer of Net Health from 2012 until 2019. Over the course of his tenure, Net Health grew from a single product startup to a multi-product, multimarket, healthcare information technology company. Prior to joining Net Health, Mr. Sanzo served as the Chief Executive Officer for TeleTracking Technologies, a company he joined in late 2001. During his tenure, the company evolved from a workflow automation startup focusing on hospital support services to the world market and innovation leader in patient flow automation, capacity management and related operations improvements. With more than 800 clients in three countries, TeleTracking grew to become the largest vendor in its market. Prior to TeleTracking, Mr. Sanzo held executive positions for two major academic medical centers and served as the Chief Executive Officer for Allegheny General Hospital for nearly a decade. Mr. Sanzo has been a board member of multiple companies and is a graduate of Allegheny College and Duke University’s Fuqua School of Business.